Study shows PromarkerD ability to also predict late-stage kidney decline in type-2 diabetes patients
The Company is pleased to announce the results of a study demonstrating the potential ability of...
Related posts
Proteomics International Laboratories soared 13 per cent after its shares came out of voluntary...
Medical technology company Proteomics International Laboratories (ASX: PIQ) has announced a...